October 19: Life Sci SIG: Constructing a Solid Provisional Patent (early bird until week before)
Medical device AND pharma AND Bioscience Entrepreneurs and Inventors will want to hear these people and learn how to do a provisional patent, on your own, or low budget.
We have two life science CEOs who have done a lot themselves. Learn from them first hand and save time, money, anguish.
- Sean D. Detweiler, Attorney, Morse, Barnes-Brown & Pendleton
- Dr. Stanley F. Chalvire, Senior Attorney, Morse, Barnes-Brown & Pendleton
- Dr. Kryngle Daly, CEO, KBioSim and KBioBox — Case Example
- Paul Hayre, CEO, Sano — Case Example
Sean D. Detweiler, Attorney, Morse, Barnes-Brown & Pendleton, P.C. is a Registered Patent Attorney and a member of the firm’s Intellectual Property practice. His work encompasses all areas of intellectual property law including: utility and design patent preparation and prosecution, trademark registration, domain name dispute resolution, and the provision of patentability and non-infringement opinions. He routinely advises clients on matters regarding intellectual property portfolio development, strategy, and implementation.
In the patent space, he works primarily in the high-technology fields of medical devices, mechanical and electrical devices, robotics, consumer retail products, computer software (including system software, application software, enterprise software, Internet e-commerce, cloud-computing, iOS/Android applications, and voice recognition software), telecommunications, and combination technologies. An additional area of focus includes ornamental designs protected with design patents. In the trademark space, he works primarily on trademark registration and enforcement.
Sean graduated Bucknell University with a BS in mechanical engineering and received his JD from Pierce Law (now UNH School of Law).
Dr. Stanley F. Chalvire, Senior Attorney, Morse, Barnes-Brown & Pendleton, P.C is a Registered Patent Attorney, specializing in patent prosecution, licensing of intellectual property and related counseling. Stan focuses his practice on counseling clients in developing and implementing strategies to protect their intellectual property, particularly in the areas relating to pharmaceuticals and biotechnology.
He has experience in matters involving pharmaceutical formulations and drug delivery technologies, genomics, proteins, drug screening and identification, small molecule pharmaceuticals and related methods of treatment, as well as experience preparing and prosecuting design patents to protect the ornamental features of consumer products.
Stan has advised clients with respect to the preparation and prosecution of utility patents and design patents, the evaluation of intellectual property portfolios in association with the licensing of pharmaceutical products from third parties, and counseling his clients with respect to regulatory exclusivity matters. He has advised clients regarding the development and implementation of life cycle management strategies regarding their key products, the preparation of pre-litigation strategies in anticipation of Abbreviated New Drug Applications (ANDA) filings referencing those products and the subsequent representation of the company in Hatch-Waxman patent litigation.
Stan is a graduate of Massachusetts College of Pharmacy and Health Sciences holding the degrees of BS, pharmacy and Doctor of pharmacy. Stan earned his J.D. from Suffolk University Law School, where he successfully completed the health and biomedical law academic concentration, focusing his legal studies on matters which are pertinent to clients in the life sciences and biomedical industries.
Kryngle Daly, is a PhD in physics specializing in the modeling of biological systems and, twenty five years of programming experience, with the last ten years specializing in scientific computing on HPC systems, afford him the ability to provide novel
in-silico techniques to the life sciences. Kryngle has successfully combined the aforementioned three fields to complete
projects in simulating macular degeneration, active transport by molecular motors, and bacterial lysis. His company KBioSim specializes in customized life science software packages and fast prototyping of medical devices, particularly medical devices requiring electronic components.
Recently Kryngle started KBioBox to provide ultra-high-speed genomic analysis. KBioBox uses novel patent pending algorithms to achieve previously unattainable bioinformatic analysis, analysis required in a wide range of applications from gene editing to clinical diagnostics.
Kryngle holds a BS in Physics from UMass and a PhD in Physics from Clark University, and completed a post doc at WPI.
Paul Hayre brings entrepreneurialism and fact-based market strategies to business building in both large or small firms. In prior roles, as interim President and SVP-Americas of Cencorp, Paul pivoted Cencorp from an ailing Telecom legacy into Cleantech by focusing on high efficiency back contact solar components, equipment, and modules. While VP New Growth at Avery, Paul crystallized multiple relevant CleanTech sector insights into a business plan, ultimately creating the global Avery CleanTech division. He founded a catering services firm in 2001, Vmeals Boston, and also currently advises other growth companies and entrepreneurs (including Cencorp). He sold Vmeals Boston in 2009 to its largest competitor and recently founded and is commercializing a novel, point-of-care chronic inflammatory disease diagnostic platform company with first focus on human chronic wounds.
Paul holds a BS Electrical Engineering Cornell University and MBA Harvard Business School, 1999. Rollins Award.
Moderated by Patti Durr.
November 16: Bootstrapping a Life Science Company.
Led by Kartik Shah.
Committee: Kryngle Daly, Patti Durr, Peter Allen, Kartik Shah, Jerry Shapiro, Mark Hediger
Committee Co-Chairs, Jerry Shapiro and Barbara Finer